Found 8 hits for monomerid = 50311912 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50311912
(4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propyl...)Show SMILES CN1CCN(CCCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C34H36F3N9O/c1-23-11-12-24(32(47)41-26-8-5-7-25(20-26)34(35,36)37)19-28(23)43-33-42-27-9-3-4-10-29(27)46(33)31-21-30(39-22-40-31)38-13-6-14-45-17-15-44(2)16-18-45/h3-5,7-12,19-22H,6,13-18H2,1-2H3,(H,41,47)(H,42,43)(H,38,39,40) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of LCK |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM50311912
(4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propyl...)Show SMILES CN1CCN(CCCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C34H36F3N9O/c1-23-11-12-24(32(47)41-26-8-5-7-25(20-26)34(35,36)37)19-28(23)43-33-42-27-9-3-4-10-29(27)46(33)31-21-30(39-22-40-31)38-13-6-14-45-17-15-44(2)16-18-45/h3-5,7-12,19-22H,6,13-18H2,1-2H3,(H,41,47)(H,42,43)(H,38,39,40) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 494 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of SRC |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Insulin receptor
(Homo sapiens (Human)) | BDBM50311912
(4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propyl...)Show SMILES CN1CCN(CCCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C34H36F3N9O/c1-23-11-12-24(32(47)41-26-8-5-7-25(20-26)34(35,36)37)19-28(23)43-33-42-27-9-3-4-10-29(27)46(33)31-21-30(39-22-40-31)38-13-6-14-45-17-15-44(2)16-18-45/h3-5,7-12,19-22H,6,13-18H2,1-2H3,(H,41,47)(H,42,43)(H,38,39,40) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.86E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused InsR expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50311912
(4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propyl...)Show SMILES CN1CCN(CCCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C34H36F3N9O/c1-23-11-12-24(32(47)41-26-8-5-7-25(20-26)34(35,36)37)19-28(23)43-33-42-27-9-3-4-10-29(27)46(33)31-21-30(39-22-40-31)38-13-6-14-45-17-15-44(2)16-18-45/h3-5,7-12,19-22H,6,13-18H2,1-2H3,(H,41,47)(H,42,43)(H,38,39,40) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 117 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused KDR expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50311912
(4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propyl...)Show SMILES CN1CCN(CCCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C34H36F3N9O/c1-23-11-12-24(32(47)41-26-8-5-7-25(20-26)34(35,36)37)19-28(23)43-33-42-27-9-3-4-10-29(27)46(33)31-21-30(39-22-40-31)38-13-6-14-45-17-15-44(2)16-18-45/h3-5,7-12,19-22H,6,13-18H2,1-2H3,(H,41,47)(H,42,43)(H,38,39,40) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused LCK expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lyn
(Homo sapiens (Human)) | BDBM50311912
(4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propyl...)Show SMILES CN1CCN(CCCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C34H36F3N9O/c1-23-11-12-24(32(47)41-26-8-5-7-25(20-26)34(35,36)37)19-28(23)43-33-42-27-9-3-4-10-29(27)46(33)31-21-30(39-22-40-31)38-13-6-14-45-17-15-44(2)16-18-45/h3-5,7-12,19-22H,6,13-18H2,1-2H3,(H,41,47)(H,42,43)(H,38,39,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 84 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused LYN expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM50311912
(4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propyl...)Show SMILES CN1CCN(CCCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C34H36F3N9O/c1-23-11-12-24(32(47)41-26-8-5-7-25(20-26)34(35,36)37)19-28(23)43-33-42-27-9-3-4-10-29(27)46(33)31-21-30(39-22-40-31)38-13-6-14-45-17-15-44(2)16-18-45/h3-5,7-12,19-22H,6,13-18H2,1-2H3,(H,41,47)(H,42,43)(H,38,39,40) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 364 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused SRC expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase HCK
(Homo sapiens (Human)) | BDBM50311912
(4-methyl-3-(1-(6-(3-(4-methylpiperazin-1-yl)propyl...)Show SMILES CN1CCN(CCCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C34H36F3N9O/c1-23-11-12-24(32(47)41-26-8-5-7-25(20-26)34(35,36)37)19-28(23)43-33-42-27-9-3-4-10-29(27)46(33)31-21-30(39-22-40-31)38-13-6-14-45-17-15-44(2)16-18-45/h3-5,7-12,19-22H,6,13-18H2,1-2H3,(H,41,47)(H,42,43)(H,38,39,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of HCK |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |